EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population genomics and clinical risk factors in a tertiary hospital, 2016-2025

Shenyun Cao, Peng Wang, Yonghua Liu, Lijuan Qi, Xinying Wang, Lin Li, Zhijun Zhang

Frontiers in Cellular and Infection Microbiology · 02.06.2026 · 16

DOI: 10.3389/fcimb.2026.1821740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 02.06.2026. Verfasst von Shenyun Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Enterobacteriaceae Infections, Body Fluids, Carbapenems. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To clarify the molecular epidemiology, resistance gene profiles, virulence characteristics, and clinical prognosis-related factors of Carbapenem-Resistant Enterobacterales (CRE) isolated from sterile body fluids. This study provides microbiological evidence for clinical management and infection control surveillance.

Methods

62 non-duplicate sterile fluid CRE strains from 2016–2025 were retrospectively analyzed. VITEK-2 Compact detected MICs per CLSI M100. Illumina NovaSeq whole-genome sequencing was assembled via ABySS and GapCloser. Databases analyzed resistance, virulence, plasmid and MLST profiles. SNP phylogenetic analysis identified clonal clusters and strain genetic relationships.

Results

Among the 62 CRE isolates, Klebsiella pneumoniae was the predominant species (77.4%, 48/62), followed by Escherichia coli (12.9%, 8/62) and Enterobacter cloacae complex (6.5%, 4/62). Additionally, single isolates of Klebsiella aerogenes and Citrobacter freundii were recovered. A total of 6 sequence types (STs) were identified, with ST11 being the most prevalent (87.5%, 42/48) among K. pneumoniae isolates. Carbapenemase genes were detected in 91.7% (44/48) of K. pneumoniae strains, with blaKPC-2 (85.4%, 41/48) and blaNDM-1 (10.4%, 5/48) as the main types. Three strains co-harbored blaKPC-2 and blaNDM-1, and one strain carried blaNDM-5 alone. These strains also carried class C β-lactamase (AmpC), extended-spectrum β-lactamases (ESBLs), and aminoglycoside/quinolone resistance genes. The rmpA2 virulence gene was detected in 75.0% (36/48) of K. pneumoniae isolates. Among E. coli, blaNDM-5 (4/8) and blaNDM-13 (2/8) were predominant. One ST155 isolate exhibited ertapenem resistance potentially mediated by AmpC promoter mutations and porin loss based on genomic prediction. Additionally, mcr-1.1 was detected in one ST361 isolate. All four E. cloacae complex belonged to ST171 and harboured blaNDM-1; one co-carried mcr-9.1. Clonal analysis revealed five major clusters within ST11 (Clade A-E), with Clade B comprising genetically related dual-carbapenemase isolates from multiple wards (8-10 SNPs). Twelve patients (19.4%) died. Intensive Care Unit (ICU) admission was significantly associated with mortality (83.3% vs. 30.0%, P=0.002).

Conclusions

CRE from sterile body fluids were dominated by ST11 K. pneumoniae carrying blaKPC-2, with complex multidrug resistance and frequent carriage of rmpA2 and other virulence-associated genes. Continuous molecular surveillance of dominant clones and monitoring of high-risk patient populations may inform strategies to reduce CRE burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsBody FluidsCarbapenemsHumansTertiary Care CentersMicrobial Sensitivity Testsbeta-LactamasesAnti-Bacterial AgentsRetrospective StudiesRisk FactorsBacterial ProteinsMultilocus Sequence TypingPhylogenyWhole Genome SequencingMolecular EpidemiologyVirulence FactorsPlasmidsGenomicsVirulence

Stichwörter der Autor:innen

ST11carbapenem-resistant enterobacteraleshypervirulencermpA2sterile body fluids

Substanzen

beta-LactamasesAnti-Bacterial AgentsBacterial ProteinscarbapenemaseCarbapenemsVirulence Factors

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
  • Shandong Provincial Key Medical and Health Laboratory of Anti-Drug Resistant Drug Research, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
  • Department of Laboratory Medicine, Jinan Nanshan People's Hospital, Jinan, China.
  • Department of Laboratory Medicine, Binhai New Area Hospital of Traditional Chinese Medicine (TCM), Tianjin, China.
  • Department of Hematology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
  • Pharmacy Intravenous Admixture Services, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.

Zitieren

APA

Cao, S., Wang, P., Liu, Y., Qi, L., Wang, X., Li, L., & Zhang, Z. (2026). Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population genomics and clinical risk factors in a tertiary hospital, 2016-2025. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1821740

Vancouver

Cao S, Wang P, Liu Y, Qi L, Wang X, Li L, et al. Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population genomics and clinical risk factors in a tertiary hospital, 2016-2025. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1821740

BibTeX
@article{Cao2026,
  author = {Cao, Shenyun and Wang, Peng and Liu, Yonghua and Qi, Lijuan and Wang, Xinying and Li, Lin and Zhang, Zhijun},
  title = {Carbapenem-resistant enterobacterales in sterile body fluids: ten-year population genomics and clinical risk factors in a tertiary hospital, 2016-2025},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1821740}
}
Kostenlos starten →